Triopsy Medical, Inc.

AURORA, CO · Founded 2012 · Medtech · Private

Advanced biopsy system for precise prostate tissue sampling

Claim this profile

Follows are private to you and power your alerts

Updated · triopsy.com

Sector
Medtech
Headquarters
AURORA, CO
Founded
2012
Latest Form D
$100K, Feb 2024
Total capital
$4.2M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$4.2M
7 Form D · last Feb 2024
32 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

20162018202020222024FEDERAL ↑EQUITY ↓Cumulative $4.2M3rd Form D$850K5th Form D$250K7th Form D$100K
20162018202020222024FEDERAL ↑EQUITY ↓Cumulative $4.2M

Latest events

  • Private capital raisedForm D · SEC · 7th filing$100K
  • Private capital raisedForm D · SEC · 6th filing$1.5M
  • Private capital raisedForm D · SEC · 5th filing$250K
  • Private capital raisedForm D · SEC · 4th filing$45K
  • Private capital raisedForm D · SEC · 3rd filing$850K
  • Private capital raisedForm D · SEC · 2nd filing$84K
  • Private capital raisedForm D · SEC · 1st filing$1.4M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings
  • Brad BuscherExecutive Officer, DirectorNamed in SEC Form D filings
  • David BostwickExecutive Officer, DirectorNamed in SEC Form D filings
  • David Crawford, MDDirectorNamed in SEC Form D filings
  • Deborah WittmanDirectorNamed in SEC Form D filings
  • James LousararianDirectorNamed in SEC Form D filings
  • John HarperDirectorNamed in SEC Form D filings
Show all 9 people
  • Michael MontagDirectorNamed in SEC Form D filings
  • Richard LarsonDirectorNamed in SEC Form D filings
  • Todd AndersonExecutive OfficerNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

  • CereVascSimilar federal contract value in Medtech · null in contracts
  • Luminoah, Inc.Similar federal contract value in Medtech · null in contracts
  • G-Tech Medical, Inc.Similar federal contract value in Medtech · null in contracts
  • FreMon Scientific, Inc.Similar federal contract value in Medtech · null in contracts
  • MiRTLE Medical LLCSimilar federal contract value in Medtech · null in contracts
  • Stork Labs Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .